Asaf Danziger

2015

In 2015, Asaf Danziger earned a total compensation of $9.7M as Chief Executive Officer at NovoCure, a 453% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$478,772
Option Awards$8,263,713
Salary$642,111
Other$271,296
Total$9,655,892

Danziger received $8.3M in option awards, accounting for 86% of the total pay in 2015.

Danziger also received $478.8K in non-equity incentive plan, $642.1K in salary and $271.3K in other compensation.

Rankings

In 2015, Asaf Danziger's compensation ranked 553rd out of 13,638 executives tracked by ExecPay. In other words, Danziger earned more than 95.9% of executives.

ClassificationRankingPercentile
All
553
out of 13,638
96th
Division
Manufacturing
189
out of 5,190
96th
Major group
Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks
25
out of 760
97th
Industry group
Surgical, Medical, And Dental Instruments And Supplies
16
out of 466
97th
Industry
Surgical and Medical Instruments and Apparatus
6
out of 293
98th
Source: SEC filing on March 28, 2017.

Danziger's colleagues

We found two more compensation records of executives who worked with Asaf Danziger at NovoCure in 2015.

2015

Michael Ambrogi

NovoCure

Chief Operating Officer

2015

Wilhelmus Groenhuysen

NovoCure

Chief Financial Officer

News

In-depth

You may also like